Biosafe Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
- Paid Up Capital ₹ 0.11 M
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.30 M
- Revenue Growth %
- Ebitda
- Net Worth 13.43%
- Total Assets 32.39%
About Biosafe Remedies
Biosafe Remedies Private Limited (BRPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 2001 and has a history of 23 years and two months. Its registered office is in Alwar, Rajasthan, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹0.30 M.
Nilesh Agarwal, Sudarshan Singh, and Sugan Gupta serve as directors at the Company.
Company Details
-
Location
Alwar, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2001PTC017291
-
Company No.
017291
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Biosafe Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Agarwal
|
Director | 30-Sep-2004 | Current |
|
Sudarshan Singh
|
Director | 21-Nov-2001 | Current |
|
Sugan Gupta
|
Director | 04-Aug-2010 | Current |
Financial Performance of Biosafe Remedies.
Biosafe Remedies Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 13.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosafe Remedies?
In 2017, Biosafe Remedies had a promoter holding of 77.27% and a public holding of 22.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.30 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jul 2010 | Bank Of Baroda | ₹0.30 M | Open |
How Many Employees Work at Biosafe Remedies?
Unlock and access historical data on people associated with Biosafe Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosafe Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosafe Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.